course-details-portlet

FARM3005

Drug Manufacturing and Quality Systems

Credits 7.5
Level Second degree level
Course start Autumn 2026
Duration 1 semester
Language of instruction Norwegian
Location Trondheim
Examination arrangement Aggregate score

About

About the course

Course content

This course will give students an understanding of drug production, with regard to formulation technology and the systems that ensure that drugs of satisfactory quality are produced.

Learning outcome

Knowledge

After completing the course, the student should have

  • in-depth knowledge of quality assurance in pharmaceutical handling.
  • in-depth knowledge of quality requirements, quality assurance and control of key steps in the development and production of pharmaceuticals.
  • knowledge of storage and distribution of pharmaceuticals.
  • knowledge of validation processes for laboratory buildings, medical equipment and manufacturing processes.
  • knowledge of the structure, roles and division of responsibilities in GMP.

Skills

After completing the course, the student can

  • propose strategies for the formulation of new radiopharmaceuticals.
  • link different parts of a batch production to relevant chapters in GMP.
  • contribute to documenting drug quality to regulatory authorities.
  • contribute to developing quality systems for drugs.
  • handle production technical deviations according to GMP.

General competence

After completing the course, the student has an understanding of

  • characteristic aspects of the manufacture of radiopharmaceuticals with a short physical half-life.
  • how consistent quality work contributes to patient safety in the pharmaceutical field.
  • which quality aspects must be taken care of before releasing a drug for clinical use.

Learning methods and activities

Lectures and assignments, mandatory attendance at one hour group work and four lectures.

Compulsory assignments

  • Attendance

Further on evaluation

Mandatory activity: Attendance at least 1 hour of group work and 4 lectures.

Written school exam and group assignment with oral presentation. The student must have gotten approved the mandatory activity in order to take the exam and group assignment. The written exam counts 70% of the overall grade, and the group assignment with oral presentation counts 30% of the overall grade. Both sub-assessments must be passed in order to receive an overall grade for the course.

Retake/re-sit of the exam: The student must have approved the mandatory activity in order to take the exam. If this has been completed and approved in a previous semester, this is sufficient to take the exam. When repeating the exam, the student can choose to only register for one of the sub-assessments in the course. In the event of a postponed exam, the exam format may be changed.

Specific conditions

Admission to a programme of study is required:
Pharmacy (MFARMASI)

Required previous knowledge

Admission to Master of Science in Pharmacy (MFARMASI) is required.

Course materials

Will be announced in the beginning of the semester.

Subject areas

  • Pharmacy

Contact information

Course coordinator

Department with academic responsibility

Department of Clinical and Molecular Medicine

Examination

Examination

Examination arrangement: Aggregate score
Grade: Letter grades

Ordinary examination - Autumn 2026

School exam
Weighting 70/100 Examination aids Code D Duration 2 hours Exam system Inspera Assessment Place and room Not specified yet.
Oral exam
Weighting 30/100 Examination aids Code A Duration 1 hours

Re-sit examination - Spring 2027

School exam
Weighting 70/100 Examination aids Code D Duration 2 hours Exam system Inspera Assessment Place and room Not specified yet.
Oral exam
Weighting 30/100 Examination aids Code A Duration 1 hours